Skip to main content

Lunai Bioworks Inc.

LNAI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001527728

No open-market purchases or sales by Lunai Bioworks Inc. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $641.0K in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Lunai Bioworks Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Lunai Bioworks Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Lunai Bioworks Inc.
NameTitleLast reported holdingLast filingFilings, past year
William Anderson Wittekind10% Owner3,353,878Mar 12, 20250
Fuentes NathenChief Financial Officer–Feb 25, 20250
van Tilburg MauriceDirector250,000Feb 25, 20250
Collins Mark AnthonyDirector–Nov 7, 20240
McNulty James ADirector–Nov 6, 20240
Calder Douglas WDirector–Nov 6, 20240
Tarsh SimonInterim CFO–Nov 6, 20240
Weinstein David HershelChief Executive Officer250,000Oct 29, 20240
Miller AvramDirector166,667Aug 27, 20240
Brink KarenDirector, 10% Owner25,372,969IndirectAug 16, 20240
Alton Gregg HDirector–Jun 27, 20240
Sapirstein JamesDirector–Jun 27, 20240
Brosgart Carol LDirector–Jun 27, 20240
Sindlev ReneDirector, 10% Owner13,605,297IndirectJun 27, 20240
McNicol JayneDirector–Jun 27, 20240
Hendriks RuudDirector–Jun 27, 20240
Abildgaard Ole10% Owner6,898,482IndirectFeb 20, 20240
Dybul MarkChief Executive Officer–Feb 16, 20240
Puche LuisaChief Financial Officer16,266Feb 16, 20240
Binette FrancoisCOO and Executive VP for R&D–Feb 16, 20240
Boeren LeniDirector–Oct 25, 20230
Gronfeldt-Sorensen HenrikDirector–Oct 19, 20230
Weird Science LLC10% Owner1,313,499Feb 6, 20230
Sandler Carl Forest JrOther: Former director see note below4,449,104Aug 3, 20220
Gumrukcu Serhat10% Owner12,273,059May 20, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Oct 24, 2024 (view filing)Jul 2987 daysLateWilliam Anderson Wittekind10% OwnerSSale−1.11K$1.30−$1.45K−0.1%840.3K after
Jul 19, 2024 (view filing)Jul 172 daysWilliam Anderson Wittekind10% OwnerSSale−16.4K$1.46−$23.9K−1.9%841.4K after
Jul 17, 2024 (view filing)Jul 152 daysWilliam Anderson Wittekind10% OwnerSSale−22.0K$1.41−$31.0K−2.4%875.8K afterAmended
Jul 15, 2024 (view filing)Jul 9-116 daysWilliam Anderson Wittekind10% OwnerSSale−94.5K$1.51−$142.8K−9.5%897.7K afterAmended3 lots
Jul 8, 2024 (view filing)Jul 3-55 daysWilliam Anderson Wittekind10% OwnerSSale−110.0K$1.53−$168.5K−10.1%974.3K after2 lots
Jul 3, 2024 (view filing)Jul 1-22 daysWilliam Anderson Wittekind10% OwnerSSale−94.6K$1.55−$146.8K−8.0%1.08M after2 lots
Jun 27, 2024 (view filing)Jun 25-272 daysWilliam Anderson Wittekind10% OwnerSSale−84.7K$1.56−$132.1K−6.7%1.18M after3 lots
Jun 18, 2024 (view filing)Jun 144 daysWilliam Anderson Wittekind10% OwnerSSale−50.0K$1.58−$79.0K−3.8%1.26M after
May 20, 2022 (view filing)May 182 daysGumrukcu Serhat10% OwnerSSale−253.5K$8.00−$2.03M−2.0%12.3M after2 lots
May 20, 2022 (view filing)May 182 daysSindlev ReneDirector, 10% OwnerPPurchase+253.5K$8.00+$2.03MNew position128.5K after2 lots
Mar 24, 2022 (view filing)Mar 222 daysSandler Carl Forest JrDirector, 10% OwnerSSale−1.93K$9.06−$17.5K−0.1%3.19M after
Feb 23, 2022 (view filing)Feb 18-235 daysSandler Carl Forest JrDirector, 10% OwnerSSale−6.80K$9.03−$61.4K−0.2%3.19M after2 lots